BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1652756)

  • 1. Human immunodeficiency virus induction of malignant transformation in human B lymphocytes.
    Laurence J; Astrin SM
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7635-9. PubMed ID: 1652756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus activates c-myc and Epstein-Barr virus in human B lymphocytes.
    Astrin SM; Laurence J
    Ann N Y Acad Sci; 1992 May; 651():422-32. PubMed ID: 1318011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic rearrangement of C-MYC oncogene occurs prior to infection with Epstein-Barr virus in the monoclonal malignant B cells from an AIDS patient.
    Roncella S; Di Celle PF; Cutrona G; Carbone A; Sessarego M; Landonio G; Foà R; Rowe M; Ferrarini M
    Leuk Lymphoma; 1993 Jan; 9(1-2):157-64. PubMed ID: 8386576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes.
    Murphy WJ; Funakoshi S; Beckwith M; Rushing SE; Conley DK; Armitage RJ; Fanslow WC; Rager HC; Taub DD; Ruscetti FW
    Blood; 1995 Sep; 86(5):1946-53. PubMed ID: 7544649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification and deregulation of MYC following Epstein-Barr virus infection of a human B-cell line.
    Lacy J; Summers WP; Watson M; Glazer PM; Summers WC
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5838-42. PubMed ID: 3039510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological and phenotypical changes in EBV positive lymphoblastoid cells infected by HIV-1.
    De Rossi A; Calabro ML; D'Andrea E; Panozzo M; Saggiori D; Mammano F; Roncella S; Ferrarini M; Chieco-Bianchi L
    Leukemia; 1992; 6 Suppl 3():38S-40S. PubMed ID: 1318475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.
    Polack A; Hörtnagel K; Pajic A; Christoph B; Baier B; Falk M; Mautner J; Geltinger C; Bornkamm GW; Kempkes B
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10411-6. PubMed ID: 8816814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regressing nude mouse grafts of Burkitt's lymphoma x lymphoblastoid cell hybrids show deregulation of the c-myc gene and expression of the EBV latent membrane protein.
    Wolf J; Klevenz B; Pawlita M; Komitowski D; Moldenhauer G; zur Hausen H
    Int J Cancer; 1991 Jan; 47(1):99-104. PubMed ID: 1702406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered HIV expression and EBV-induced transformation in coinfected PBLs and PBL subpopulations.
    Henderson EE; Yang JY; Zhang RD; Bealer M
    Virology; 1991 May; 182(1):186-98. PubMed ID: 1708929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marker rescue of a transformation-negative Epstein-Barr virus recombinant from an infected Burkitt lymphoma cell line: a method useful for analysis of genes essential for transformation.
    Marchini A; Kieff E; Longnecker R
    J Virol; 1993 Jan; 67(1):606-9. PubMed ID: 8380096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-infected marmoset cells transfected with c-myc do not form lymphomas in mice with severe combined immunodeficiency.
    Salimi B; O'Gorman MR; Variakojis D; Bendet M; Newman M; Poupko E; Katz BZ
    Mol Genet Metab; 1998 Jul; 64(3):205-12. PubMed ID: 9719630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection of Epstein-Barr virus-transformed lymphoblastoid B cells by the human immunodeficiency virus: evidence for a persistent and productive infection leading to B cell phenotypic changes.
    De Rossi A; Roncella S; Calabro ML; D'Andrea E; Pasti M; Panozzo M; Mammano F; Ferrarini M; Chieco-Bianchi L
    Eur J Immunol; 1990 Sep; 20(9):2041-9. PubMed ID: 2170147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of human immunodeficiency virus (HIV) on the cytotoxic response to Epstein Barr virus (EBV) transformed B lymphocytes.
    Blumberg RS; Paradis TJ; Crawford D; Byington RE; Hirsch MS; Schooley RT
    AIDS Res Hum Retroviruses; 1987; 3(3):303-15. PubMed ID: 2829951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
    Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
    Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable morphology of human immunodeficiency virus-associated lymphomas with c-myc rearrangements. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors, I.
    Delecluse HJ; Raphael M; Magaud JP; Felman P; Alsamad IA; Bornkamm GW; Lenoir GM
    Blood; 1993 Jul; 82(2):552-63. PubMed ID: 8392399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epstein-Barr virus associated lymphocyte proliferation].
    Stein H; Hummel M; Anagnostopoulos I; Korbjuhn P; Niedobitek G; Dallenbach F; Herbst H
    Verh Dtsch Ges Pathol; 1992; 76():79-95. PubMed ID: 1283280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus gene expression during primary B-lymphocyte infection, in transformed and Burkitt lymphoma-derived cell lines.
    Ernberg I; Kallin B; Dillner J
    Curr Top Microbiol Immunol; 1986; 132():251-6. PubMed ID: 3024918
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of EBV-positive lymphoblastoid cell lines obtained from HIV seropositive patients with or without lymphomas.
    Roncella S; Di Celle PF; Cutrona G; Carbone A; Sessarego M; Dodi F; Foa R; Rowe M; Ferrarini M
    Leukemia; 1992; 6 Suppl 3():12S-14S. PubMed ID: 1318463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.